Shareholding disclosure

OrbiMed Advisors LLC

Declared position

6.09%

Threshold

Crossed upwards

Timeline

Published

19.07.2018

Transaction

13.07.2018

Voting rights breakdown

Voting rights acquired6.09%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAI7G00089

Beneficial owner

OrbiMed Advisors LLC

Declared address

OrbiMed Advisors LLC, New York

Listing of Issuer's shares on SIX Swiss Exchange.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

OrbiMed Advisors LLC

ObsEva SA19.07.2018TAI7G00089

Disclosure summary

OrbiMed Advisors LLC disclosed a holding in ObsEva SA on the acquisition side, published by SIX Exchange Regulation on 19.07.2018, at 6.09% of voting rights. Notice category: Single shareholder.

Disclosed position

6.09%

Voting rights acquired

Voting rights acquired6.09%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

OrbiMed Advisors LLC disclosed a holding in ObsEva SA, published on 19.07.2018.

Publication date19.07.2018

Transaction date13.07.2018

Issuing companyObsEva SA

Beneficial ownerOrbiMed Advisors LLC

Declared addressOrbiMed Advisors LLC, New York

CategorySingle shareholder

Voting rights acquired6.09%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAI7G00089

Conditions

Listing of Issuer's shares on SIX Swiss Exchange.

Source: SIX Exchange Regulation · Publication date: 19.07.2018

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open